In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
We scan the top radiology sources so you don’t have to.
From AI breakthroughs to imaging trends, we serve up real-time radiology insights.
-
SNMMI: PET tracer images brain inflammation
A PET radiotracer can produce high-quality, real-time images of brain inflammation, which may help with diagnosing and treating…
-
Video from SNMMI: Cathy Cutler on the state of the field in 2025
Current SNMMI President Cathy Cutler, PhD, discusses the state of the field in 2025 and the challenges ahead.
-
Thermo Fisher Scientific Awarded Contract to Supply Navy with Advanced Radiation Detection Systems
tim.hodson
Tue, 06/24/2025 – 11:13
June 23, 2025 — On June 23, 2025, Thermo Fisher Scientific announced it has been awarded a five-year, $94.5 million contract by the U.S. Department of Defense (DoD) to supply the Navy with a next-generation dosimetry system alongside updated radiation health and database management software.
The U.S. Navy operates the world’s most technologically advanced naval fleet and is the largest defense user of dosimetry systems globally. With this award, T… -
SNMMI: PET approach finds more inflammation in PAOS patients
A novel PET imaging approach could help in better managing patients with progressive apraxia of speech (PAOS).
-
SNMMI: Novel adaptive radiotherapy system improves tumor response monitoring
Initial results from UT Southwestern Medical Center may advance adaptive radiation therapy.
-
Simpler Lung Cancer Screening Criteria May Still Maintain Diagnostic Efficiency
(MedPage Today) — Expanding eligibility criteria for lung cancer screening (LCS) to include 20-year smoking history without requiring a certain number of pack-years maintained diagnostic efficacy while reducing disparities, estimates from a cohort…
-
FDA Grants Expanded Approval for Illuccix in Patient Selection for Pre-Taxane Radioligand Therapy
The additional indication for the preparation kit of gallium Ga-68 gozetotide may facilitate earlier use of PSMA-targeted treatment for men with prostate cancer.
-
Mid-Gestation Assessment of Small-for-Gestational-Age Risk
Mid-gestation assessment of the risk for small for gestational age can help identify pregnancies needing additional monitoring beyond routine care, improving outcomes for those at high risk. Medscape News UK
-
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
In a recent interview at SNMMI conference, Merle Hoenig, Ph.D., discussed new tau PET research examining genetic and modifiable risk factors that contribute to the progression of Alzheimer’s disease.